Glanbia Stock CINNOBER BOAT

Equities

GLB

IE0000669501

Food Processing

Delayed CINNOBER BOAT 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Glanbia -.--% -.--%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 3.55B 3.86B Sales 2025 * 3.92B 4.26B Capitalization 4.72B 5.13B
Net income 2024 * 291M 316M Net income 2025 * 312M 339M EV / Sales 2024 * 1.39 x
Net Debt 2024 * 229M 248M Net Debt 2025 * 26.33K 28.62K EV / Sales 2025 * 1.2 x
P/E ratio 2024 *
16.2 x
P/E ratio 2025 *
15.1 x
Employees -
Yield 2024 *
2.12%
Yield 2025 *
2.28%
Free-Float 69.82%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 53 Dec. 31
Director of Finance/CFO 60 13-01-11
Public Communications Contact - 14-11-30
Members of the board TitleAgeSince
Director/Board Member 63 14-11-30
Director/Board Member 68 20-10-31
Director/Board Member 59 20-12-31
More insiders
Glanbia plc specializes in the production and commercialization of dairy, nutritional and food products for the food and pharmaceutical industries. Net sales break down by product family as follows: - nutritional and functional ingredients (66.9%): dairy, vegetable and functional proteins, nutrients (vitamins, trace elements, minerals, etc.), nutritional supplements for children, bioactive ingredients, etc. for dairy and non-dairy products (drinks, cereal bars, snacks, sauces, animal feed, etc.). The group is also developing a cheese production activity; - performance nutrition products (33.1%; world n°1): notably sports nutrition products (Optimum Nutrition, BSN, Isopure, thinkThin, Nutramino, ABB, Body & Fit and Amazing Grass brands). Net sales are distributed geographically as follows: Ireland (0.3%), Europe (8.7%), the United States (79.2%), North America (2%), Asia/Pacific (7%), Latin America (1.8%) and other (1%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
18.11 EUR
Average target price
20.61 EUR
Spread / Average Target
+13.80%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW